BIOCAPTIVA LIMITED
PrivateLast Round
Seed
Mar 9, 2026
Total Funding Raised
$6.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BIOCAPTIVA LIMITED operates in Healthcare & Life Sciences and is based in Midlothian. Its latest recorded funding round was a Seed round in March 2026.
BIOCAPTIVA LIMITED is a biotechnology company that develops proprietary polymer-based medical devices and technologies to improve liquid biopsy testing for cancer management and research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOCAPTIVA LIMITED Comparables
Compare BIOCAPTIVA LIMITED with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nRichDX | 79% | |
| Qiagen | 74% | |
| CellBio Scientific | 72% |
For institutional investors. Book with your work email.
BIOCAPTIVA LIMITED Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 9, 2026 | ||||
| Seed | Jun 1, 2022 | ||||
| Seed | Apr 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BIOCAPTIVA LIMITED Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Horizons | Seed |
| EverQuest Capital Partners | Seed |
| BBI Capital | Seed |
| Old College Capital | Seed |
| Archangel Investors | Seed |
| Cancer Research Horizons | Seed |
| Scottish Investment Bank (Scottish Enterprise) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2026
Alan Schafer appointed as the new CTO.
- Mar 9, 2026
Developing cfdna extraction kits with new funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 12, 2026
On Aug 12th '26, BioCaptiva Limited appoints Stephane Argivier as Chair to steer its next phase of international growth, succeeding Frank Armstrong.
For institutional investors. Book with your work email.
BIOCAPTIVA LIMITED Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BIOCAPTIVA LIMITED's valuation, stock price, and market status.
Is BIOCAPTIVA LIMITED a public or private company?
BIOCAPTIVA LIMITED is a private company.
What is the current stock price of BIOCAPTIVA LIMITED?
BIOCAPTIVA LIMITED is a private company, so its shares have no public market price. Caplight tracks BIOCAPTIVA LIMITED's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BIOCAPTIVA LIMITED worth (valuation)?
Valuation information for BIOCAPTIVA LIMITED is not publicly available.
Can I buy BIOCAPTIVA LIMITED stock?
BIOCAPTIVA LIMITED shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BIOCAPTIVA LIMITED's last funding round?
BIOCAPTIVA LIMITED's most recent funding round was Seed on March 9, 2026.
Who are the main investors in BIOCAPTIVA LIMITED?
Key investors in BIOCAPTIVA LIMITED include Archangel Investors.
Will BIOCAPTIVA LIMITED IPO soon?
No public IPO plans have been announced for BIOCAPTIVA LIMITED.
How can I track BIOCAPTIVA LIMITED secondary market activity?
Caplight tracks bids, offers, and trades in BIOCAPTIVA LIMITED's shares on secondary markets.